Sheffield, July 01, 2025 (GLOBE NEWSWIRE) — UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss Rincell-1 addresses a multi $Bn global market opportunity where no disease modifying treatments currently exist Sheffield, UK, July 1 2025 – Rinri Therapeutics, a world leading company focused on transforming […]

FTI Consulting Appoints Joseph Shipley to Lead Private Equity Offering within the Strategic Communications Segment in London and across EMEA GlobeNewswire July 01, 2025 LONDON, July 01, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Joseph Shipley as a Senior Managing Director within the Strategic Communications segment, where he

At OpenInfra Summit Europe, the community will showcase how OpenStack, Kubernetes, Kata Containers, Ceph, StarlingX, RISC-V and other projects are tackling a $9 trillion demand for open source software Open source infrastructure solutions for digital sovereignty, VMware migration, and AI workloads will be in the spotlight as members of the OpenInfra Foundation and its global

Hemispherian AS, a pioneering biotech company developing next-generation therapeutics for aggressive cancers, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for GLIX1 for the treatment of malignant glioma, a category of devastating brain cancers that includes glioblastoma. https://mma.prnewswire.com/media/2721951/Hemispherian_Logo.jpg Significant clinical benefit beyond current therapies. The designation marks

Proven to achieve a breakeven for initial investment in less than six months, ensuring rapid recovery of compliance costs while optimizing efficiency gains Sumsub, a global full-cycle verification platform, today announced the release ofits commissioned Total Economic Impact™ (TEI) study conducted by Forrester Consulting. The study aims to examine the potential return on investment (ROI)

UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class Regenerative Cell Therapy for Sensorineural Hearing Loss Rincell-1 addresses a multi $Bn global market opportunity where no disease modifying treatments currently exist GlobeNewswire July 01, 2025 Sheffield, July 01, 2025 (GLOBE NEWSWIRE) — UK MHRA Approval Received for First-In-Human Trial of Rincell-1, a First-In-Class

From July 29 to 31, 2025,WEPACK Southeast Asia, organized byRX China,will make its highly anticipated debut at the Jakarta International Expo (JIEXPO), held in parallel with the Paper Chain Expo. This marks the first time these two exhibitions will be co-located, forming a comprehensive platform that links upstream papermaking with downstream packaging applications. The combined

— Report to be released at approximately 7:00 AM CEST on July 15, 2025 — One live video webcast for analysts, investors and journalists at 9:00 AM CEST Ericsson's (NASDAQ: ERIC) financial report for the second quarter 2025 will be published at approximately 7:00 AM CEST on July 15, 2025. The company will issue a

Copenhagen , July 01, 2025 (GLOBE NEWSWIRE) — Under the new contract, ISS will deliver integrated facility services across sites in 12 countries in Northern and Central Europe. These include a wide range of services such as cleaning, waste management, catering, reception, and outdoor maintenance. The contract will be mobilised in Denmark from 1 October

Burford Capital Limited (“Burford”), the leading global finance and asset management firm focused on law, today issues the following update on two significant developments yesterday. US Budget Reconciliation Bill With reference to Burford's prior June 17 and June 30, 2025 statements in connection with proposed tax provisions relating to litigation finance included within the US